Crestline Management’s Juno Therapeutics, Inc. JUNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-7,631,631
| Closed | -$349M | – | 270 |
|
|
2017
Q4 | $349M | Sell |
7,631,631
-1,717,168
| -18% | -$78.5M | 35.74% | 1 |
|
|
2017
Q3 | $419M | Sell |
9,348,799
-8,033,393
| -46% | -$360M | 58.3% | 1 |
|
|
2017
Q2 | $520M | Buy |
17,382,192
+33,393
| +0.2% | +$998K | 69.6% | 1 |
|
|
2017
Q1 | $385M | Hold |
17,348,799
| – | – | 70.45% | 1 |
|
|
2016
Q4 | $327M | Hold |
17,348,799
| – | – | 81.61% | 1 |
|
|
2016
Q3 | $521M | Hold |
17,348,799
| – | – | 66.02% | 1 |
|
|
2016
Q2 | $667M | Hold |
17,348,799
| – | – | 100% | 1 |
|
|
2016
Q1 | $654M | Sell |
17,348,799
-8,600,000
| -33% | -$324M | 100% | 1 |
|
|
2015
Q4 | $1.13B | Hold |
25,948,799
| – | – | 100% | 1 |
|
|
2015
Q3 | $1.06B | Sell |
25,948,799
-40,000
| -0.2% | -$1.63M | 100% | 1 |
|
|
2015
Q2 | $1.39B | Sell |
25,988,799
-1,095,726
| -4% | -$58.4M | 100% | 1 |
|
|
2015
Q1 | $1.64B | Hold |
27,084,525
| – | – | 100% | 1 |
|
|
2014
Q4 | $1.41B | Buy |
+27,084,525
| New | +$1.41B | 100% | 1 |
|